- Case report
- Open Access
- Open Peer Review
Pyomyositis is not only a tropical pathology: a case series
© The Author(s). 2016
- Received: 11 February 2016
- Accepted: 24 November 2016
- Published: 21 December 2016
Pyomyositis is an acute bacterial infection of skeletal muscle that results in localized abscess formation. This infection was thought to be endemic to tropical countries, and is also known as “tropical pyomyositis”. However, pyomyositis is increasingly recognized in temperate climates and is frequently associated with an immunosuppressive condition, such as human immunodeficiency virus, malignancy, and diabetes mellitus. It is also found in healthy and athletic people after strenuous or vigorous exercise or following localized and possibly unnoticed trauma. It can be primary or secondary to neighboring or remote infection. Primary pyomyositis is a rare condition that can affect children and adolescents. Diagnosis can be delayed because the affected muscle is deeply situated and local signs are not apparent. This delay in diagnosis can result in increased morbidity and a significant mortality rate. The pediatric population, which comprises 35% of the reported pyomyositis cases, is an especially difficult subset of patients to diagnose.
In our series, we describe the cases of four previously healthy Caucasian children who were admitted to our Pediatric Department with different clinical presentations. Pyomyositis in our patients was related to factors affecting the muscle itself, including strenuous exercise and direct muscle trauma. Therapy was started with a cephalosporin antibiotic and teicoplanin was subsequently added. The minimum length of therapy was 3 weeks.
The diagnosis of pyomyositis in our patients, none of whom were immune-compromised, is confirmation that this disease is not an exclusive pathology of tropical countries and demonstrates that there is an increasing prevalence of pyomyositis in temperate climates.
- Muscle infection
- Case report
- Tropical pathology
Pyomyositis is a bacterial infection that results in an intramuscular abscess of the large skeletal muscle groups. The first case was documented by Scriba in Japan in 1885  but the first report in North America did not appear until 1971 . This infection is endemic to tropical countries, accounting for 2.2–4% of surgical admissions . It is much less common in temperate climates, such as North America, where only 98 cases were reported between 1972 and 1992 . In tropical countries, peak incidence is at 2–5 years of age; in North America, the mean age is 8.4 years with a range of 1–16 years .
Primary pyomyositis is common in many parts of Africa and in the South Pacific, and has earned the name “tropical pyomyositis.” It occurs more frequently in immune-compromised patients, though it can be related to factors affecting the muscle itself (strenuous exercise, direct muscle trauma, viral or parasitic myositis) . Secondary pyomyositis is usually a consequence of direct extension from an infectious process, most notably Crohn’s disease, infectious colitis, appendicitis, and neoplasia. The pathogenesis of the disease is not clear, but trauma, malnutrition, viral and parasitic infections, bacteremia, immunodeficiency or chronic illness, and other factors may have predisposing roles . Intensive exercise and local trauma have been suggested as risk factors, but only a third of patients had evidence of these risk factors . Because of its rarity and often vague clinical presentation, it is unlikely to be considered during an initial differential diagnosis. Moreover, the diagnosis can be delayed because the affected muscle is deeply situated and local signs are not apparent. This delay in diagnosis can result in increased morbidity and a significant mortality rate . The pediatric population, which comprises approximately 35% of reported cases, is an especially difficult subset of patients to diagnose .
If the disease is recognized early, antibiotic therapy alone is usually sufficient. Initial therapy should include a broad-spectrum agent with adequate Staphylococcus aureus coverage, and therapy should subsequently be modified depending on results of blood culture and sensitivity tests. Coverage of Gram-negative organisms should be empirically included in the treatment of immunocompromised patients. The therapy is initially administered intravenously and generally lasts 3–4 weeks but the duration can vary considerably .
A 6–5/12-year-old Caucasian boy was admitted to our Pediatric Department with fever, pharyngitis, lateral cervical and inguinal lymphadenomegaly, limp, and pain in his proximal right thigh (medial side) during walking and on palpation. Prior to admission, he had a 12-day history of intermittent-remittent fever up to 39.3 °C, treated with paracetamol (acetaminophen). At admission, his C-reactive protein (CRP) concentration was 7.17 mg/dl (normal value <0.5 mg/dl) and he had leukocytosis (white blood cells (WBC) 19.36 × 103/μl) and neutrophilia (15.77 × 103/μl; 81.4%). For this reason, intravenous antibiotic treatment with ceftriaxone was started. Right lower limb venous ultrasonography excluded phlebitis or phlebothrombosis. Nevertheless, his CRP concentration increased to 15.90 mg/dl, his erythrocyte sedimentation rate (ESR) was 51 mm/h (normal value <20 mm/h), and there was a further increase in his leukocytosis (WBC 22.30 × 103/μl) and neutrophilia (17.94 × 103/μl; 80.5%); his antistreptolysin O (ASO) titer was 451 UI/ml (normal value <200 UI). Ultrasonography of his thigh muscles and hip was performed, showing a minimal fluid intrafascial thickening of his proximal adductor muscle. Double antibiotic therapy with ceftriaxone and teicoplanin was therefore started. Magnetic resonance imaging (MRI) with contrast confirmed the proximal thickening of his right proximal longus and magnus adductor muscles and ipsilateral proximal gracilis muscle, attributable to an inflammatory process, without any involvement of his joints. Results from subsequent laboratory tests showed a reduction in inflammatory markers (CRP 0.77 mg/dl, ESR 14 mm/h), an improvement in leukocyte (13.99 × 103/μl) and neutrophil (9.07 × 103/μl; 64.8%) concentrations, and normalization of his ASO titer. On the eighth day of treatment, the ceftriaxone therapy was interrupted and teicoplanin was administered for a further 7 days. At discharge, after normalization of his laboratory test results, oral therapy with amoxicillin plus clavulanic acid was started for an additional 7 days. A control MRI scan highlighted a nearly complete resolution of the pyomyositis in both muscles with a regression of fever, limp, and pain. The length of therapy was 3 weeks.
A 15-year-old Caucasian boy presented to our Pediatric Department with pain in his right buttock that began a week after a 3-km run and a bowling match, with radiation of the pain in his lumbar region that was aggravated by movement and an inability to walk unaided. There were no associated abdominal or urinary symptoms. Before admission, he had fever up to 39 °C. A physical examination showed fever (38.2 °C), right low back pain, a positive result on a leg raise test, and functional limitation in his right lower limb. He had some discomfort in his right groin on deep palpation to his right buttock lateral to the ischial tuberosity. Our patient was unable to ambulate independently but his muscle tone, strength, and reflexes were preserved. No sensory deficit of his right lower limb was noted. There ere no palable inguinal lymph nodes.
Initial laboratory studies revealed leukocytosis and neutrophilia (15 × 103/μl; 90%), a CRP concentration of 15.80 mg/dl (normal value <0.5 mg/dl), and an ESR of 54 mm/h (normal value <20 mm/h). Involvement of the lower limb nerve was suspected. Routine radiography of both his hips and pelvis demonstrated no abnormalities. He was started on diclofenac for the pain and oral antibiotic treatment with amoxicillin plus clavulanic acid. An MRI of his lumbosacral spine and pelvis was performed; the examination showed an increased silhouette on his right side associated with areas of altered signal in the iliopsoas muscle, obturator, and gluteus medius and maximus. Some fluid collection (the largest of which measured up to 6 cm on the craniocaudal diameter), edema between the paraspinal muscles at L4–L5, and bilateral edema of the plan of dermal-subcutaneous thigh root were also reported in the posterolateral view. The antibiotic therapy was therefore replaced with ceftazidime and teicoplanin. A blood sample, taken on the 14th day of antibiotic therapy, showed a decrease in inflammatory markers (CRP 2.41 mg/dl, ESR 14 mm/h) and in neutrophilic leukocytosis (WBC 12.6 × 103/μl, neutrophils 8.5 × 103/μl). A control MRI scan highlighted a slight reduction in the fluid collections in his iliopsoas and obturator muscles, with the fluid collection in his gluteal muscles converted into an abscess, characterized by a mildly hyperintense labrum on T1-weighted MRI. At discharge, after normalization of his laboratory test results, oral therapy with amoxicillin plus clavulanic acid was started for an additional 4 weeks. The total length of therapy was 6 weeks.
An 8-year-old Caucasian boy presented to our Pediatric Department with a 1-week history of fever, pain, and impairment in walking owing to left leg pain. Before admission, he was treated with cephalosporin (ceftriaxone), acetaminophen, and ketoprofen without benefit. No association with trauma or previous infection was reported, but a knee injury was observed. A physical examination showed antalgic positioning of his left hip, warmth and pain on palpation of the proximal posterior region of his left leg, and stiffness and pain during leg movements. Neurological, respiratory, and cardiovascular examinations were normal. Laboratory tests documented an increased CRP concentration (6.25 mg/dl, normal value <0.5 mg/dl), ESR (72 mm/h, normal value <20 mm/h), leukocyte count (WBC 15.85 × 103/μl), and creatine phosphokinase (CPK) (237 U/L). He had positive titer tests for ASO (648 UI/ml) and anti-staphylococcal antibodies. Owing to the suspicion of a S. aureus infection, a double therapy with cephalosporin and glycopeptide antibiotics (ceftriaxone plus teicoplanin) was undertaken for 8 days. A hip X-ray documented reactive changes in the lesser trochanter of his femur and an ultrasound scan showed a hematoma at the proximal third of the posterior side of his thigh. MRI showed inflammation of his obturator and adductor magnus muscles. Our patient was discharged on oral antibiotic therapy for 10 days. The follow-up visits documented a gradual resolution of symptoms, normal laboratory test results, and reduced muscle inflammation in an MRI scan. No drainage was necessary. The length of therapy was 3 weeks. A few months later our patient was symptom free.
A 10–6/12-year Caucasian girl presented to our Pediatric Department with pain localized to her right thigh for 8 days’ duration, with significant movement restriction, an inability to bear weight, and fever (up to 39.7 °C). Our patient had been treated at home with anti-inflammatory therapy (ibuprofen). Normal results were seen on ultrasonography of her right hip and on right pelvic and hip radiography. On examination, our patient had an attitude of flexion and adduction in her right hip, evident restriction of her right lower limb movements, and painful passive mobilization. The pain worsened when the proximal adductor region was palpitated. There was also swelling over the medial side of the root of her thigh. Laboratory studies showed elevated CRP levels (14.4 mg/dl, normal value <0.5 mg/dl), a slight increase in lactic dehydrogenase values (712 U/l), and neutrophilia (10.7 × 103/μL; N: 7:57 × 103/μL). Her ESR was not measured in the emergency room. Septic arthritis was suspected and intravenous antibiotic therapy with ceftazidime and anti-inflammatory therapy with ibuprofen were started. MRI of her pelvis and lumbosacral spine demonstrated intra-articular effusion of her right hip joint with short TI inversion recovery (STIR) hyperintensity in her ipsilateral adductor muscles. Follow up blood tests documented a progressive reduction of CRP (1.29mg/dL); ESR: 47 mm/h) and normalization of her WBC count (7.12 × 103/μL). Results from a Widal-Wright test and blood culture were negative. Results from a urine analysis were normal. Owing to a positive anti-staphylococcal antibody titer, teicoplanin was added to her ceftazidime therapy. During her hospitalization, our patient’s clinical condition progressively improved: her fever disappeared in 10 days with remission of the painful limitation to active and passive motions of her right hip after 12 days, and subsequent recovery of ambulation. Our patient was discharged with an oral course of amoxicillin-clavulanate treatment, thus completing a 3-week cycle of antibiotic therapy. A second MRI was performed after therapy completion, which showed nearly complete resolution of the inflammatory changes. At a 1-month follow-up, our patient was symptom free without sequelae.
About 2% of patients present in this stage. This stage lasts from 10 to 21 days.
Insidious onset of dull, cramping pain, a low-grade fever, muscle ache, general malaise, and anorexia. There is localized edema, sometimes described as indurated or woody, with little or no tenderness. There is no abscess, and examination of aspiration specimens is unrevealing.
Purulent or suppurative
About 90% of patients present in this stage. In one study, the mean duration of symptoms before hospitalization was 24 days, whereas in other studies it was respectively 12 days and 6.2 days. Fever and chills. This phase is characterized by abscess formation. Pathologic findings on biopsy show edematous muscle fibers, lymphocytic infiltration, and suppuration as the muscle belly is replaced by pus.
The involved muscle is usually tender and the overlying skin may be normal or mild eruptive.
High fever, severe pain, local signs of infection and systemic manifestations of sepsis may be present. The final stage is characterized by septicemia, metastatic abscesses, and multi-organ dysfunction, and is associated with high mortality.
There is exquisite tenderness of the involved area.
Laboratory investigations are not specific and are rarely helpful in the diagnosis of pyomyositis . In our series, we reported the same laboratory findings as found in previous studies, such as moderate leukocytosis with a left shift, elevation of ESR and CRP, and normal muscle enzyme levels , although an increase in CPK was also documented in case 3. Three cases involved an elevated ASO titer and two had positive staphylococcal antibody titers. Imaging is the best modality to define the features and the extent of muscle infection.
Various noninvasive diagnostic modalities such as ultrasound, computed tomography (CT), and MRI have been used to evaluate patients with suspected musculoskeletal infection . Plain radiography is appropriate for the initial screening . Only a minority of patients have findings suggestive of muscle inflammation. X-rays was performed only in case number 3 and it failed to document the specific reactive change in the adjacent bone. A CT scan provides better delineation of muscle than X-rays and can identify a muscle abscess, but it may fail to demonstrate inflammatory changes in earlier stages . In our series, no CT scans were performed when ultrasonography was used. The typical findings on radiography are a bulky muscle with abnormal echotexture and a hypoechoic focal lesion, occasionally with internal debris and air bubbles [8, 14]. In our cases, ultrasonography allowed visualization of significant muscle inflammation. MRI is the gold standard, showing the extent of involvement and the site of fluid collection. It offers the additional advantage of being able to study the adjacent structures, such as joints, bone, and soft tissue , and is therefore helpful to differentiate other pathological processes from pyomyositis , such as infectious arthritis of the hip, osteomyelitis, hematoma, or soft-tissue tumor . All four of our patients underwent MRI, which was very helpful in defining the appropriate therapy. In three cases, MRI was also repeated to evaluate the resolution of inflammation. Technetium or gallium scintigraphy is rarely used in the diagnosis of pyomyositis, but it may assist the diagnostic process when the clinical presentation is equivocal .
Specific site of tenderness and swelling
Osteomyelitis, septic arthritis 
Fever and abdominal pain
Muscular hematoma, rupture, or strain
Localized muscular mass, painless slow-growing masses, painful mass increasing in size
Pain in right lower quadrant, back, flank, or hip; fever
Acute appendicitis or acute disease of hip or femoral nerve 
Myalgia, weakness, tea-colored urine
The choice of treatment is usually related to the stage of disease at presentation. Prompt, accurate diagnosis followed by early initiation of intravenous antibiotics can prevent abscess formation and avoid surgical drainage . In the early invasive stage, in the absence of a drainable collection of purulent fluid on MRI, diffuse inflammation can be treated empirically with antibiotics alone . On the basis of the most likely culpable bacteria, cloxacillin is a common choice. A combination of cloxacillin and aminoglycoside achieves a synergic effect for septic or immunocompromised patients . Most patients with primary pyomyositis can be treated successfully with intravenous administration of a single antibiotic. In our series, the therapy was started empirically with a double antibiotic therapy with cephalosporin and glycopeptide antibiotics (ceftriaxone, cefixime, or ceftazidime plus teicoplanin) for at least 2 weeks to cover S. aureus and Gram-negative infection. Antibiotic therapy was discontinued when physical signs and symptoms disappeared and blood test results and CRP concentration returned to normal values. The duration of therapy has not been established and can vary from 2 to 6 weeks, depending on clinical severity and the patient’s response. Patients who have an underlying disease that compromises their immunity may require a longer period of intravenous and oral antibiotic treatment .
Abscess formation, however, requires appropriate drainage before starting antibiotics. Because most patients are not seen until an abscess has already formed (stages 2 and 3), drainage followed by intravenous administration of at least two broad-spectrum antibiotics remains the treatment of choice . When the pathogenic agent is isolated, antibiotic therapy should be adjusted according to the result of culture and sensitivity tests . In many series, despite abscess formation in some patients, neither surgical nor percutaneous drainage are needed. Traditionally, abscesses were drained by operative means, which entailed a large skin incision and a wide exposure of the affected muscle. Similarly, iliopsoas pyomyositis necessitated laparotomy and extensive retroperitoneal exposure. Following operative drainage, packing and daily dressing changes were necessary to prevent the abscess cavity from closing prematurely . However, now drainage can be accomplished percutaneously under ultrasound or CT guidance, and operative intervention is used only when complete drainage cannot be achieved percutaneously. Streptococcal pyomyositis is associated with extensive muscle necrosis that requires not only abscess drainage, but also radical excision of all necrotic tissues. When there has been a delay in diagnosis, a more extensive debridement and, rarely, amputation may be needed . A diagnostic delay could lead to sepsis and death , so it is very important to choose the correct diagnostic approach.
Pyomyositis in our series was related to factors affecting the muscle itself, including strenuous exercise and direct muscle trauma. The gold standard for diagnosing pyomyositis is MRI. Ultrasonography is useful for monitoring muscle inflammation. In our series, therapy was started with a cephalosporin antibiotic and teicoplanin was subsequently added to cover S. aureus infection. The minimum length of treatment was 3 weeks. Our patients, none of whom were immune-compromised, lived in a temperate climate, confirming that pyomyositis is not an exclusive pathology of tropical countries.
We express our gratitude to patients and their families for participating in this study.
Supported by the Paediatric Department of the University of Chieti.
Availability of data and materials
Data available on request from the authors.
LC, PIG, GP, and SF were the attending physicians of these patients. MIP and PD reviewed the literature. LC drafted the manuscript. AM, FC, and NR reviewed the literature and the manuscript. All authors read and approved the final manuscript.
The authors declare that they have no competing interests.
Consent for publication
Written informed consent was obtained from the patients’ legal guardians for publication of this case report and any accompanying images. Copies of the written consents are available for review by the Editor-in-Chief of this journal.
Ethics approval and consent to participate
Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
- Taksande A, Vilhekar K, Gupta S. Primary pyomyositis in a child. Int J Infect Dis. 2009;13(4):e149–51. doi:10.1016/j.ijid.2008.08.013.View ArticlePubMedGoogle Scholar
- Levin MJ, Gardner P, Waldvogel FA. Tropical pyomyositis. N Engl J Med. 1971;284:196–8.View ArticlePubMedGoogle Scholar
- Christin L, Sarosi GA. Pyomyositis in North America: case reports and review. Clin Infect Dis. 1992;15:668–77.View ArticlePubMedGoogle Scholar
- Khoshhal K, Abdelmotaal HM, Alarabi R. Primary obturator internus and obturator externus pyomyositis. Am J Case Rep. 2013;14:94–8.View ArticlePubMedPubMed CentralGoogle Scholar
- Crum NF. Bacterial pyomyositis in the United States. Am J Med. 2004;117:420–8.View ArticlePubMedGoogle Scholar
- Nikolopoulos DD, Apostolopoulos A, Polyzois I, et al. Obturator internus pyomyositis in a young adult: a case report and review of the literature. Cases J. 2009;2:85–8.View ArticleGoogle Scholar
- Bertrand SL, Lincoln D, Prohaska MG. Primary pyomyositis of the pelvis in children: a retrospective review of 8 cases. Orthopedics. 2011;34:832–40.Google Scholar
- Bickels J, Ben-Sira L, Kessler A, Wientroub S. Primary pyomyositis. J Bone Joint Surg. 2002;84-A:2277–86.View ArticlePubMedGoogle Scholar
- Fan HC, Lo WT, Chu ML, Wang CC. Clinical characteristics of staphylococcal pyomyositis. J Microbiol Immunol Infect. 2002;35(2):121–4.PubMedGoogle Scholar
- Mitsionis GI, Manoudis GN, Lykissas MG, Sionti I, Motsis E, Georgoulis AD, et al. Pyomyositis in children: early diagnosis and treatment. J Pediatr Surg. 2009;44(11):2173–8.View ArticlePubMedGoogle Scholar
- Brown JD, Wheeler B. Pyomyositis: report of 18 cases in Hawaii. Arch Intern Med. 1984;144:1749–51.View ArticlePubMedGoogle Scholar
- Marath H, Yates M, Lee M, Dhatariya K. Pyomyositis. J Diabet Complications. 2011;25:346–8.View ArticleGoogle Scholar
- Klein-Kremer A, Jassar H, Nachtigal A, Zeina AR. Primary pyomyositis in a young boy. Isr Med Assoc J. 2010;12(8):511–3.PubMedGoogle Scholar
- Chen WS, Wan YL. Iliacus pyomyositis mimicking septic arthritis of the hip joint. Arch Orthop Trauma Surg. 1996;115:233–5.View ArticleGoogle Scholar
- Agarwal V, Chauhan S, Gupta RK. Pyomyositis. Neuroimaging Clin N Am. 2011;21(4):975–83.View ArticlePubMedGoogle Scholar
- Chong XL, et al. Obturator internus pyomyositis in a child: a case report. Malays Orthop J. 2014;8(1):69–70.View ArticlePubMedPubMed CentralGoogle Scholar
- Tong CW, Griffith JF, Lam TP, Cheng JC. The conservative management of acute pyogenic iliopsoas abscess in children. J Bone Joint Surg (Br). 1998;80:83–5.View ArticleGoogle Scholar
- Kennedy CA, Mathisen G, Goetz MB. Tropical pyomyositis of the abdominal wall musculature mimicking acute abdomen. West J Med. 1990;152:296–8.PubMedPubMed CentralGoogle Scholar
- Mangell P, Bohe M, Almqvist P, Ekberg O, Anaqnostaki L. Pyomyositis--a differential diagnosis in the acute abdomen. Eur J Surg. 1997;163(7):553–5.PubMedGoogle Scholar
- Dhanoa A, Singh VA, Vijayananthan A. Primary pyomyositis mimicking soft-tissue sarcoma: a case report. Br J Med Med Res. 2013;3(1):189–97.View ArticleGoogle Scholar
- Johnson CJ, Pynsent PB, Grimer RJ. Clinical features of soft tissue sarcomas. Ann R Coll Surg Engl. 2001;83(3):203–5.PubMedPubMed CentralGoogle Scholar
- Giannoglou GD, Chatzizisis YS, Misirli G. The syndrome of rhabdomyolysis: pathophysiology and diagnosis. Eur J Intern Med. 2007;18(2):90–100.View ArticlePubMedGoogle Scholar
- Elsayed EF, Reilly RF. Rhabdomyolysis: a review, with emphasis on the pediatric population. Pediatr Nephrol. 2010;25(1):7–18.View ArticlePubMedGoogle Scholar